Controlled release of biomolecules from temperature-sensitive hydrogels prepared by radiation polymerization.
Poly(acryloyl-L-proline methyl ester)-based hydrogels containing 1 and 5% of a crosslinking agent were studied as drug delivery systems. The drug loading properties were investigated by matrix incubation into solutions containing biomolecules with molecular weight ranging between 300 and 65,000 Da. The loading yield was found to depend on both the crosslinking degree and the molecular weight of the drug. In vitro release studies were carried out with both swollen and dry matrices loaded with gentamicin, isoniazid and insulin. Gentamicin and isoniazid were released by a bimodal Fickian diffusion with a remarkable burst that was found to depend on both matrix crosslinking degree and physical state. In vivo, the subcutaneous implantation into mice of the isoniazid loaded matrices allowed for an efficient drug release for 800 h. In vitro insulin was released from the swollen matrices for 1500 h by diffusional Fickian mechanism while the dry ones displayed a lag time followed by Fickian diffusion release. The subcutaneous implantation of the insulin-loaded matrices into diabetic mice induced a remarkable decrease in the glucose concentrations in blood. In particular, the dry 1% matrices were found to maintain a low glucose level for 700 h.
Caliceti
P
P
Department of Pharmaceutical Sciences, University of Padua, Via F. Marzolo 5-35131 Padua, Italy. caliceti@dsfarm.unipd.it
Salmaso
S
S
Lante
A
A
Yoshida
M
M
Katakai
R
R
Martellini
F
F
Mei
L H
LH
Carenza
M
M
D000818:Animals; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003692:Delayed-Action Preparations; D004343:Drug Implants; D005079:Excipients; D020100:Hydrogels / Q000138:chemical synthesis / Q000737:chemistry* / Q000528:radiation effects; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D007328:Insulin / Q000008:administration & dosage / Q000493:pharmacokinetics; D007538:Isoniazid / Q000008:administration & dosage / Q000737:chemistry; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008970:Molecular Weight; D011108:Polymers / Q000138:chemical synthesis / Q000528:radiation effects; D011506:Proteins / Q000008:administration & dosage* / Q000737:chemistry; D013696:Temperature
D003692:Delayed-Action Preparations; D004343:Drug Implants; D005079:Excipients; D020100:Hydrogels; D007004:Hypoglycemic Agents; D007328:Insulin; D011108:Polymers; D011506:Proteins; D007538:Isoniazid